Journal of Virology & Antiviral ResearchISSN: 2324-8955

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, J Virol Antivir Res Vol: 5 Issue: 1

Assessment of T-Cell Immunoregulatory Cytokine Patterns for Liver Fibrosis in Chronic Hepatitis B Patients Before and After Interferon Therapy

Rakesh Kumar Shrivastava1*, Sourav Sen2 and Praharaj AK3
1Department of Microbiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
2Department of Microbiology, Army Hospital (Research & Referral), Delhi Cantt, New Delhi, India
3Department of Microbiology, AIIMS, Bhubaneswar, Odisha, India
Corresponding author : Rakesh Kumar Shrivastava
Department of Microbiology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
Tel: +91 7697459010
E-mail: [email protected]
Received: December 30, 2015 Accepted: March 02, 2016 Published: March 09, 2016
Citation: Shrivastava KR, Sen S, Praharaj AK (2016) Assessment of T-Cell Immunoregulatory Cytokine-Patterns for Liver Fibrosis in Chronic Hepatitis B Patients Before and After Interferon Therapy. J Virol Antivir Res 5:1. doi:10.4172/2324-8955.1000151

Abstract

Many of the chronic hepatitis B patients have a higher risk of developing liver disease, such as cirrhosis and/or hepatocellular carcinoma. Cytokines play an important role in the host response to hepatitis B virus (HBV) infection. Present study was planned to assess the T-cell immunoregulatory cytokine patterns in chronic hepatitis B patients & correlate them in response to interferon therapy. Study comprised of two groups. Group A included 25 treatment naïve chronic hepatitis B patients. Group B included 25 chronic hepatitis B patients who had received 4 to 6 months of peg interferon treatment. Control group included 25 apparently healthy individuals. Assessment of cytokines was done by quantitative type of sandwich ELISA. Pre and post treatment viral load was determined by real time PCR. HBeAg was done by ELISA. HBV DNA levels in group A patients was 1.4 x 107 copies/ml, and HBeAg positivity was 18/25. HBV DNA levels in group B patients were 5.2 x 105 copies/ml, and HBeAg positivity was 08/25. When compared to cytokine patterns, TH2 associated cytokines were significantly higher in group A patients (P<0.01), and TH1 associated cytokines were significantly higher in group B patients. Interferon therapy might be effective in decreasing the viral burden, and in turn may delay the progression of chronic liver disease. Out of the four cytokines assessed, IL-18, and IL-4 can be used as a marker of response to Interferon therapy.

Keywords: Hepatitis; T-cell; Interferon therapy; Liver fibrosis

Track Your Manuscript

Share This Page

Media Partners